Abstract:Abstract Background Retinitis pigmentosa (RP) is the most common inherited retinal degeneration. Our purpose was to describe disease-causing variants in a Chinese patient with RP. We described the clinical features and identify a novel (p.Lys1019fs) variant in DHX38 . Case presentation A 47-year-old Chinese man complained of persistent visual impairment. To clarify the diagnosis, the clinical symptoms were observed and analysed in combination with comprehensive ophthalmologic examinations and genetic analysis. Abnormal fundus manifestations were found, including thinning of retinal arteriovenous vessels, obscure reflection in macular fovea, and scattered osteocyte-like pigment in the retina. We identified two mutations of USH2A gene (c.2802T > G and c.8559-2A > G ) and one novel mutation of DHX38 gene (c.3056delA) in the proband. The parents with visual loss were heterozygous carriers. The compound heterozygous mutations in USH2A are the underlying cause of this case. And the novel variant results in the mutation of amino acid 1019 from lysine to arginine and bring a new reading frame, the 37th codon followed by the mutation site turn to be a stop codon, resulting in a premature protein truncation. Conclusions The study identified two compound heterozygous USH2A variants (c.2802T > G and c.8559-2A > G) and one novel DHX38 variants (c.3056delA) in an RP patient. It is conducive to a clearer understanding of genotype-phenotype correlation in the non-syndromic RP patients. Our study expands the spectrum of DHX38 variants in RP as well.

Correction: Retinitis pigmentosa-linked mutation in DHX38 modulates its splicing activity

Erratum: Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers

Erratum: Deconstructing transcriptional heterogeneity in pluripotent stem cells

Corrigendum: Long-range RNA Pairings Contribute to Mutually Exclusive Splicing

Retinitis pigmentosa-linked mutation in DHX38 modulates its splicing activity

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum to “knockdown of Herp Alleviates Hyperhomocysteinemia Mediated Atherosclerosis Through the Inhibition of Vascular Smooth Muscle Cell Phenotype Switching” [int. J. Cardiol. 269 (2018) 242–249]

Novel frameshift Variant c.3056delA of the DHX38 Gene in a Chinese Family With Retinitis Pigmentosa

Publisher Correction: the Transcriptional Coactivator TAZ Regulates Reciprocal Differentiation of TH17 Cells and Treg Cells.

Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins

Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Correction to: C1orf194 deficiency leads to incomplete early embryonic lethality and dominant intermediate Charcot—Marie—Tooth disease in a knockout mouse model

Publisher Correction: Molecular Basis of Vasohibins-Mediated Detyrosination and Its Impact on Spindle Function and Mitosis.

The splicing factor DHX38 enables retinal development through safeguarding genome integrity

Correction: Loss of the BMP Antagonist, SMOC-1, Causes Ophthalmo-Acromelic (Waardenburg Anophthalmia) Syndrome in Humans and Mice

ERRATUM: GH modulates hepatic epidermal growth factor signaling in the mouse

Correction to "Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes"

Correction: Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa

Correction to: P66Shc expression in diabetic rat retina

Correction: STAT6 degradation and ubiquitylated TRIML2 are essential for activation of human oncogenic herpesvirus

Erratum: Dlic1 deficiency impairs ciliogenesis of photoreceptors by destabilizing dynein